Circio
Logotype for Circio Holding

Circio (CRNA) investor relations material

Circio Status update summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Circio Holding
Status update summary15 Jan, 2026

Technology platform and innovation

  • Developed a proprietary circular RNA (circVec) platform enabling enhanced and prolonged gene expression for gene and cell therapy applications.

  • circVec offers up to 75x longer half-life and 40x higher protein expression in vivo compared to conventional mRNA approaches.

  • Demonstrated significant improvements in heart, eye, and CNS gene expression, with up to 40x increased activity in heart tissue.

  • circVec enables dose reduction in AAV gene therapy, lowering toxicity and cost while maintaining efficacy.

  • In vivo cell therapy applications show >6 months expression duration, outperforming mRNA-based approaches.

Market opportunity and partnerships

  • Targeting large patient populations in heart, eye, and CNS genetic diseases, as well as cancer and autoimmune disorders.

  • Recent industry deals in AAV gene therapy and in vivo cell therapy highlight strong commercial interest, with transactions up to $2.1 billion.

  • Entered first partnership with a global pharma company in Q4 2025, with additional collaborations targeted.

Financial update and rights issue

  • Announced an 88% underwritten and presubscribed NOK 50 million rights issue, priced at NOK 1.00 per share.

  • Rights issue supported by major shareholders, with NOK 24.2 million in presubscription commitments.

  • Funds will support operations for 12 months and enable delivery of key pre-clinical milestones, including a feasibility study with a major pharma partner.

  • Subscription period runs from 15–29 January 2026, with attached warrants exercisable in June 2026.

Quantify circVec's AAV expression advantage
Detail current pharma collaboration scope
What data triggers future partnering interest?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Circio earnings date

Logotype for Circio Holding
Q4 202510 Apr, 2026
Circio
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Circio earnings date

Logotype for Circio Holding
Q4 202510 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Circio Holding ASA, formerly known as Targovax ASA, is a biotechnology company primarily engaged in the development of innovative circular RNA (circRNA) and immunotherapy medicines. The company has pioneered a distinctive circRNA platform, aiming to create novel circRNA medicines for a variety of applications including rare diseases, vaccines, cancer treatments, protein replacement therapies, and cell therapy. The company is headquartered in Oslo, Norway, and its shares are listed on the Oslo Stock Exchange under the ticker symbol CRNA.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage